^
Association details:
Evidence:
Evidence Level:
Sensitive: C4 – Case Studies
New
Source:
Title:

Efficacy of Venetoclax and Dexamethasone in Refractory IgM Primary Plasma Cell Leukemia with t(11;14) and TP53 Mutation: A Case Report and Literature Review

Excerpt:
Our case demonstrates the efficacy of ven/dex in an aggressive and refractory pPCL patient with t(11;14) and TP53 mutation and, in this case, IgM-subtype....He progressed on proteasome inhibitors, immunomodulating agents, and other chemotherapy medications but later achieved very good partial response (VGPR) to venetoclax and dexamethasone...
Secondary therapy:
dexamethasone injection
DOI:
https://doi.org/10.1155/2020/8823877